Detalhe da pesquisa
1.
Discovery of potent and selective Spleen Tyrosine Kinase inhibitors for the topical treatment of inflammatory skin disease.
Bioorg Med Chem Lett
; 28(21): 3458-3462, 2018 11 15.
Artigo
Inglês
| MEDLINE | ID: mdl-30249354
2.
Discovery of GSK143, a highly potent, selective and orally efficacious spleen tyrosine kinase inhibitor.
Bioorg Med Chem Lett
; 21(20): 6188-94, 2011 Oct 15.
Artigo
Inglês
| MEDLINE | ID: mdl-21903390
3.
Network integration and modelling of dynamic drug responses at multi-omics levels.
Commun Biol
; 3(1): 573, 2020 10 15.
Artigo
Inglês
| MEDLINE | ID: mdl-33060801
4.
1-Aryl-3,4-dihydroisoquinoline inhibitors of JNK3.
Bioorg Med Chem Lett
; 19(8): 2230-4, 2009 Apr 15.
Artigo
Inglês
| MEDLINE | ID: mdl-19303774
5.
Comprehensive characterization of the Published Kinase Inhibitor Set.
Nat Biotechnol
; 34(1): 95-103, 2016 Jan.
Artigo
Inglês
| MEDLINE | ID: mdl-26501955
6.
N-(3-Cyano-4,5,6,7-tetrahydro-1-benzothien-2-yl)amides as potent, selective, inhibitors of JNK2 and JNK3.
Bioorg Med Chem Lett
; 17(5): 1296-301, 2007 Mar 01.
Artigo
Inglês
| MEDLINE | ID: mdl-17194588